Why the world's most famous gene editor is too big to work
In short: While CRISPR dominates the headlines, its physical size creates a massive hurdle for treating diseases inside the human body. This video explores the shift toward ultracompact tools designed to fit into the tiny delivery vehicles required for internal medicine.
Standard gene-editing tools like CRISPR are often too bulky to be packaged into viral vectors, which are the primary vehicles used to deliver genetic instructions to cells. This makes treating complex diseases that require multiple gene adjustments complicated and inefficient. To solve this, scientists have developed TIGRa, an ultracompact gene activation tool. Unlike CRISPR, TIGRa is small enough to fit inside viral vectors with room to spare, allowing it to find target genes and recruit the cell's own machinery to ramp up their expression.
Researchers at Stanford Medicine demonstrated TIGRa's potential in a mouse model to treat retinal injury. By turning up two protective genes in retinal ganglion cells, they were able to help the mice retain partial vision after injury, whereas untreated mice became nearly blind. The study, published August 10 in Cell Stem Cell, highlights how these travel-sized tools can activate dormant genes to treat conditions like glaucoma.
Opens the Intellect+ feed with this card first. Swipe up for the next one.
Sources
- Summary by Intellect · source: Editing Genes Inside the Human Body
- Also: New gene activation tool may do what CRISPR cannot: work inside the body
To cite this card, link to https://intellectplus.co.uk/app/science-editing-genes-inside-the-human-body.
How we source, check and correct cards: Editorial standards.
General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.
Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?
Related
More in Science · Latest · A–Z · All topics
